| Gene symbol | CD7 | Synonyms | GP40, LEU-9, TP41, Tp40 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | |
| Description | CD7 molecule | ||||
| GTO ID | GTC2637 |
| Trial ID | NCT04823091 |
| Disease | T-Cell Non-Hodgkin's Lymphoma | T-Cell Chronic Lymphocytic Leukemia | T-Cell Lymphocytic Leukemia |
| Altered gene | CD7 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD7 CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Anti-CD7 CAR-Engineered T Cells for T Lymphoid Malignancies Malignancies |
| Year | 2021 |
| Country | China |
| Company sponsor | Wuhan Union Hospital, China |
| Other ID(s) | CAR7-T-cells |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||||
|
|||||||||||||